Click on image to view larger version.

Fig. 10. Model for uptake mediated by cell adhesion molecules. The model shown is
for signaling pathways stimulated when monomeric ICAM-1 or anti-PECAM-1 are
clustered by binding to immunoconjugates. Pharmacological inhibitors and
activators are indicated by italics. Cell adhesion molecules have the capacity
to bind proteins that mediate direct interactions with the actin cytoskeleton,
such as
-actinin (
-act) and ERM proteins. On the basis of our
inhibitor data and results from the literature, we propose that clustering of
ICAM-1 or PECAM-1 can also stimulate PKC, Src kinase and ROCK signal
transduction pathways. This could help regulate the recruitment of other
cofactors, such as dynamin-2 (dyn2), to the plasma membrane. Also, ERM
proteins and NHE transporters are downstream targets for phosphorylation by
the Rho/ROCK pathway, which might further serve to recruit actin to sites of
immunoconjugate uptake in response to ICAM-1 or PECAM-1 clustering.